Stuart Holden

Insider Reports History

Entity
Individual
Location
C/O Urogen Pharma Ltd., 9 Ha'ta'asiya Street, Ra'anana, Israel
Signature
/s/ Jason D. Smith, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stuart Holden:

Stock Role Class Num Shares Value Price $ Report Date Ownership
UroGen Pharma Ltd. Director Stock Option (right ot buy) 10K Aug 6, 2024 Direct

Insider Reports Filed by Stuart Holden

Symbol Company Period Transactions Value $ Form Type Date Filed Role
URGN UroGen Pharma Ltd. Aug 6, 2024 1 $0 4 Aug 8, 2024 Director
URGN UroGen Pharma Ltd. Sep 7, 2023 1 $0 4 Sep 8, 2023 Director
URGN UroGen Pharma Ltd. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
URGN UroGen Pharma Ltd. Jun 7, 2021 1 $0 4 Jun 9, 2021 Director